← Evidence map

ReviewOncology letters2019

Insights on CXC chemokine receptor 2 in breast cancer: An emerging target for oncotherapy.

Fengzhu Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31788042